Hospital Gowns Market Set To Hit US$ 5.7 Billion By 2034

Overview

New York, NY – May 30, 2025 – Global Hospital Gowns Market size is expected to be worth around US$ 5.7 billion by 2034 from US$ 2.6 billion in 2024, growing at a CAGR of 8.2% during the forecast period 2025 to 2034.

The global demand for hospital gowns is witnessing steady growth, driven by increased healthcare awareness, rising hospital admissions, and heightened emphasis on infection prevention protocols. Hospital gowns play a critical role in protecting patients, healthcare workers, and caregivers from cross-contamination and healthcare-associated infections (HAIs).

Hospitals, surgical centers, and long-term care facilities remain the major end-users, with a noticeable shift toward disposable gowns due to their convenience and reduced risk of transmission. The demand for gowns made from fluid-resistant and breathable materials has surged, especially in procedures involving exposure to bodily fluids or infectious agents. The rise of multi-drug-resistant organisms (MDROs) and global pandemic preparedness efforts have further emphasized the importance of high-quality personal protective apparel.

The market is also witnessing advancements in fabric technology, with manufacturers focusing on enhancing comfort, durability, and compliance with international safety standards. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) continue to outline strict guidelines for gown classification, performance, and labeling. With healthcare infrastructure expanding in developing regions and growing investments in hospital safety, the hospital gowns market is expected to remain an essential component of global healthcare supply chains.

Key Takeaways

• In 2023, the global Hospital Gowns market generated a revenue of approximately USD 6 billion. The market is projected to decline slightly, reaching USD 5.7 billion by 2033, registering a compound annual growth rate (CAGR) of 8.2%.
• By product type, surgical gowns accounted for the largest share in 2023, representing 42.7% of total market revenue. This dominance is attributed to their essential role in maintaining sterile conditions during medical procedures.
• In terms of usability, disposable hospital gowns led the segment with a substantial market share of 58.6%. The preference for disposable gowns is driven by their convenience and effectiveness in reducing infection risks, especially in high-turnover healthcare settings.
• Based on end users, hospitals emerged as the leading segment, capturing 51.3% of the total market share in 2023. This dominance reflects the high volume of surgical procedures and patient admissions within hospital settings, necessitating consistent demand for gowns.
• Regionally, North America held the highest market share at 39.5% in 2023. The region’s leadership is supported by advanced healthcare infrastructure, high awareness of infection control measures, and increased healthcare expenditure.
• The market outlook remains influenced by technological advancements, regulatory standards, and the growing emphasis on hospital-acquired infection prevention across healthcare facilities.

Segmentation Analysis

• Product Type Analysis: In 2023, the surgical gowns segment led the market with a 42.7% share, driven by rising surgical procedures and heightened focus on infection control. Growing demand for sterile, high-quality gowns in operating rooms is propelling this segment. Innovations in fabric technology such as fluid resistance, breathability, and durability further enhance performance. As global healthcare standards evolve, particularly in developing regions, the adoption of advanced surgical gowns is expected to continue increasing.
• Usability Analysis: Disposable gowns captured a significant 58.6% market share in 2023 due to their single use convenience and strong infection control benefits. Their popularity is growing in surgical, emergency, and isolation settings where hygiene is critical. Increased awareness of hospital-acquired infections and the need to limit cross-contamination are fueling this segment. Moreover, advancements in comfort and protective qualities of disposable materials are expected to support ongoing adoption by healthcare providers worldwide.
• End-User Analysis: Hospitals dominated the hospital gowns market in 2023, accounting for 51.3% of total revenue. This was largely due to the surge in inpatient admissions, surgeries, and emergency care services. Hospitals consistently require large volumes of gowns to ensure hygiene and protect staff and patients. With growing investment in hospital infrastructure and rising emphasis on infection prevention protocols, this segment is expected to remain the key driver of demand across the global healthcare landscape.

Market Segments

Product Type

• Non-Surgical Gowns
• Surgical Gowns
• Patient Gowns

Usability

• Reusable
• Disposable

End-user

• Hospitals
• Clinics
• Others

Regional Analysis

• North America Regional Analysis: North America held the largest share of the hospital gowns market in 2023, accounting for 39.5% of total revenue. Growth is driven by robust healthcare infrastructure, rising patient volumes, and increased emphasis on patient safety and comfort. Hospitals are investing in high-quality gowns to enhance hygiene and clinical outcomes. Notably, initiatives like the Starlight Children’s Foundation’s launch of themed gowns in Texas reflect the region’s focus on improving the patient experience, particularly in pediatric care settings.
• Asia Pacific Regional Analysis: The Asia Pacific region is expected to register the fastest CAGR during the forecast period, supported by expanding healthcare systems and increasing hospital admissions. Countries such as China, India, and Japan are witnessing rising chronic disease cases and aging populations, driving gown demand. Emphasis on comfort, hygiene, and material innovation like antimicrobial and eco-friendly fabrics supports growth. Government healthcare investments and the rise of private medical facilities are further contributing to market expansion in the region.

Emerging Trends

• Shift to reusable washable gowns for sustainability and supply resilience: Reusable patient gowns have been incorporated to reduce dependence on disposable isolation gowns, with routine laundering procedures ensuring safe reuse during shortage periods.
• Adoption of antimicrobial textile treatments to inhibit pathogens: Textiles impregnated with antimicrobial agents have been developed to limit bacterial growth under hospital conditions, enhancing biosafety in patient apparel.
• Enhanced material selection guided by scientific barrier testing: Barrier performance is now determined by standardized tests that measure resistance to blood and body fluids, enabling gowns to be matched precisely to exposure risks.
• Implementation of tiered barrier performance standards (ANSI/AAMI PB70 Levels 1–4): Hospital gowns are being classified into four barrier levels based on liquid and viral penetration tests, ensuring appropriate protection from minimal to high contamination risks.
• Strengthening of regulatory requirements through updated FDA guidance: Since December 2015, all surgical gown products have been required to meet more stringent FDA premarket verification criteria, reinforcing product safety and performance.

Use Cases

• Surgical gowns as Class II medical devices: Surgical gowns are regulated by the FDA as Class II devices requiring a 510(k) premarket notification; they protect both patients and staff from transfer of microorganisms and fluids during operations.
• Isolation gowns for medium- to high-risk contamination scenarios: Surgical isolation gowns provide larger critical protection zones and are used when there is a heightened risk of exposure to blood and body fluids, as defined by FDA standards.
• Reusable patient gowns to conserve disposable supplies: During supply constraints, reusable patient gowns are laundered per CDC guidelines, offering five recognized alternatives (e.g., reusable lab coats, disposable aprons) to preserve disposable gowns.
• Protective ensembles for high-risk infectious disease management: In responses to viruses such as Ebola, gowns and coveralls are used together to form critical protective zones, ensuring comprehensive coverage of exposed areas.
• Disposable laboratory coats for nonclinical activities: For tasks involving low to moderate fluid exposure outside of patient care, disposable laboratory coats are preferred to prevent cross-contamination without the need for full-gown barrier levels.

Conclusion

The global hospital gowns market is projected to maintain steady demand, supported by the growing focus on infection prevention, patient safety, and regulatory compliance. While surgical and disposable gowns dominate due to their protective benefits and convenience, advancements in antimicrobial fabrics and reusable options are driving sustainable innovation.

Hospitals remain the key end users, with North America leading due to robust infrastructure, and Asia Pacific showing the fastest growth. Strengthened FDA and international standards further reinforce product quality and safety. As healthcare systems continue evolving, hospital gowns will remain a vital component of clinical hygiene and protective care worldwide.